Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls

FiercePharma

After global recalls of heartburn medicine Zantac and an FDA ban, the Department of Justice is investigating Sanofi and GlaxoSmithKline for possible violations of the False Claims Act.

The drugmakers last year pulled their Zantac products over an impurity believed to cause cancer, and Sanofi said the probe is over disclosures relating to that impurity.  read more »

Kodak reportedly under SEC investigation over disclosure of U.S. drug producing deal

CNBC

The SEC is looking into Eastman Kodak’s disclosure about getting awarded a $765 million loan from the U.S. government to start producing drug ingredients.

On July 27, a day before Kodak as well as President Donald Trump announced the deal, shares of the film pioneer soared nearly 25% with trading volumes far exceeding those in previous sessions. read more »